tiprankstipranks

Harry L. Leider Insider Profile

4 Followers
Harry L. Leider, Chief Medical Officer at Gelesis Holdings, holds 0.00 shares in Zeo ScientifiX (Ticker: ZEOX), holds 314.09K shares in Gelesis Holdings (Ticker: GLSHQ). Most recently, Harry L. Leider Sold ― shares of Zeo ScientifiX on Dec 20, 2023 for an estimated value of 6.87K.
tipranks
Harry L. Leider

Harry L. Leider
Gelesis Holdings (GLSHQ)
Chief Medical Officer

Not Ranked
Harry L. Leider has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$6K
100.00%
0.00%
A breakdown of Harry L. Leider's holdings

Insider Roles

Gelesis Holdings
(GLSHQ)
Chief Medical Officer
Zeo ScientifiX
(ZEOX)
CEO, Director
Roles that Harry L. Leider holds in companies

Most Profitable Insider Trade

Stock:
Zeo ScientifiX
(ZEOX)
Rating:Informative Sell
Date:Dec 20, 2023 - Today
Return:-244.80%
The most profitable trade made by Harry L. Leider

Harry L. Leider's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Gelesis Holdings
May 09, 2022
Chief Medical Officer
Uninformative Buy
$5.97K
Zeo ScientifiX
Dec 20, 2023
CEO, Director
Informative Sell
6.87K
$0.00
List of latest transactions for each holding click on a transaction to see Harry L. Leider's performance on stock

Harry L. Leider insider profile FAQ

What is the percentage of profitable transactions made by Harry L. Leider?
The percentage of profitable transactions made by Harry L. Leider is ―.
    What is the average return per transaction made by Harry L. Leider?
    The average return per transaction made by Harry L. Leider is ―.
      What stocks does Harry L. Leider hold?
      Harry L. Leider holds: GLSHQ, ZEOX stocks.
        What was Harry L. Leider’s latest transaction?
        Harry L. Leider latest transaction was an Informative Sell of $6.87K.
          What was Harry L. Leider's most profitable transaction?
          Harry L. Leider’s most profitable transaction was an Informative Sell of ZEOX stock on December 20, 2023. The return on the trade was -244.80%.
            What is Harry L. Leider's role in Gelesis Holdings?
            Harry L. Leider's role in Gelesis Holdings is Chief Medical Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.